Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Cash Flow 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -128.5M | -41.6M | 139.8M | -93.8M | -50.9M | -25.6M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 1.0M | 3.2M | 5.6M | 2.9M | 4.6M | 2.3M |
| Free Cash Flow | -129.6M | -44.7M | 134.2M | -96.7M | -55.4M | -27.9M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Entrada Therapeutics Inc. Cash Flow — FAQ
Entrada Therapeutics Inc. (TRDA) cash flow over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's cash flow history?
The chart and table above show Entrada Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.